CONTOUR® NEXT LINK BGM system: highly accurate wireless communication of
results to Medtronic insulin devices for seamless integration
1. Greene L, et al. Comparative accuracy of three blood glucose monitoring systems that communicate with an insulin pump, Endocr Pract, 2014; 1:1-29.
Proven highly accurate
Overall Mean Absolute Relative Difference (MARD) from the lab reference method† was just 2.7% 1
The CONTOUR®NEXT LINK BGM system also proven highly accurate by meetings the ISO 15197:2013* accuracy standard2
Sends results to compatible Medtronic devices (MiniMed® Paradigm REAL-Time Revel and MiniMed® Medtronic 530G with Enlite®) for fast and easy bolus dosing and Continuous Glucose Monitor (CGM) calibration
Allows for easy downloading to CareLink® software and battery recharging
allows patients to apply more blood to help prevent wasting a test strip
No CodingTM technology
Eliminates errors due to user miscoding
2. International Organization for Standardization. In vitro diagnostic test systems—requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus.Geneva,Switzerland: International Organization for Standardization; 2013
†Laboratory Reference Method = Yellow Springs Instruments. Results in the Overll Range (YSI 34 – 561 mg/dL)
*International Organization for Standardization. The ISO 15197:2013 standard requires 95% of results to fall within ±15 mg/dL of a laboratory reference value for blood glucose concentrations <100 mg/dL and within ±15% of a laboratory reference value for blood glucose concentrations ≥100 mg/dL, and 99% of individual glucose measured values shall fall within zones A and B of the Consensus Error Grid.
©2015 Bayer. All rights reserved. Bayer (reg’d), the Bayer Cross (reg’d), CONTOUR®, No Coding, Second-Chance sampling, are trademarks of Bayer. MiniMed and Enlite are registered trademarks of Medtronic MiniMed, Inc.
Questions about the CONTOUR® NEXT LINK meter from Bayer?
Find out which test strips are compatible with your meter from Bayer >